Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data MAGNACHIP SEMICONDUCTOR Corp files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
688
680
465
521
507
474
338
230
196
179
Cost of revenue
532
492
350
404
379
321
236
178
158
147
Gross profit
156
188
116
116
128
154
101
51.6
38.7
31.4
Research and development
72.2
70.5
46
45
45.7
51.2
52.3
51.6
25
27.3
Selling, general and administrative
83.5
81.8
47.7
47.6
50
52.4
50.9
48.5
38.1
35.1
Operating expenses
153
149
93.8
92.7
101
70.1
107
109
64.7
67.3
Operating income
2.74
39.2
21.9
23.7
27
83.4
-5.24
-57.6
-26
-35.9
Interest income
2.61
5.98
10.4
8.32
5.36
Other non-operating income
2.99
2.9
-0.23
2.58
0.37
1.18
0.56
0.01
0.49
0.3
Pre-tax income
-25.9
86.1
-26.9
-18.2
10.8
74
-2.88
-47.6
-35.5
-32.1
Income tax
3.74
1.16
-1.08
2.2
-46.2
17.3
5.16
-10.9
-8.2
-17.9
Income from continuing operations
-25.8
-20.4
57.1
56.7
-8.04
-36.6
-54.3
-29.7
Net income
-29.6
84.9
-3.9
-21.8
345
56.7
-8.04
-36.6
-54.3
-29.7
EBITDA
28.2
67.4
53.9
56.5
43.5
97.6
9.76
-41
-9.81
-22.9
EPS, basic
-0.85
2.50
-0.11
-0.64
9.80
1.26
-0.18
-0.89
-1.44
-0.82
EPS, diluted
-0.85
2.02
-0.11
-0.64
7.54
1.21
-0.18
-0.89
-1.44
-0.82
Shares, basic (weighted)
34.8
33.9
34.5
34.3
35.2
44.9
44.9
41
37.8
36.2
Shares, diluted (weighted)
34.8
44.8
34.5
34.3
46.5
47.7
44.9
41
37.8
36.2
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
102
129
132
152
280
280
225
158
139
104
Short-term investments
0
Receivables
61.8
92
80
47.4
64.4
51
35.4
32.6
28.4
26
Inventory
57
73.1
71.6
41.4
39
39.4
39.9
32.7
30.5
34.2
Other current assets
5.11
15.4
9.87
10
9.32
2.62
15.8
9.28
4.78
3.78
Total current assets
243
330
353
379
410
409
338
245
219
177
Property, plant and equipment
180
206
202
73.1
96.4
108
111
100
81.5
100
Lease right-of-use assets
1.88
4.63
4.28
5.27
4.64
3.11
2.07
Intangible assets
3.09
4.06
3.95
2.77
2.73
2.38
1.93
1.54
0.51
0.45
Other non-current assets
6.63
5.77
8.73
8.91
9.74
10.7
11.6
12.2
22
7.11
Total assets
442
559
583
595
572
584
517
420
379
352
Accounts payable
51.5
65.9
55.6
40.4
52.2
37.6
18
24.4
21.6
20.8
Accrued liabilities
60.4
51.7
46.3
44.8
16.2
20.1
9.69
10.5
8.65
6.93
Deferred revenue
11.1
8.34
0.55
0.56
2.68
2.38
Short-term debt
83.5
0
Total current liabilities
153
138
133
134
174
85.5
47.2
46.9
46.3
43.4
Long-term debt
221
303
304
305
0
0
27.2
44.6
Lease liabilities
0.25
2.42
1.95
4.09
2.9
1.82
0.69
Other non-current liabilities
9.42
9.59
10.4
14
10.1
10.1
3.08
Total liabilities
514
598
601
610
226
131
88.5
75.9
103
103
Total debt
221
303
304
305
83.5
0
27.2
44.6
Paid-in capital
130
136
143
152
163
241
266
273
279
282
Retained earnings
-126
-40.9
8.48
-58.1
287
344
336
299
245
215
Treasury stock
-90.9
-102
-104
-107
-108
-130
-161
-213
-226
-230
Other comprehensive income
14
-33.1
-20.1
-2.66
3.7
-2.23
-12.6
-14.7
-21.9
-18.8
Shareholders' equity
-72.1
-39.6
-17.3
-15
346
453
428
345
277
248
Total equity
-72.1
-39.6
-17.3
-15
346
453
428
345
277
248
Total liabilities and equity
442
559
583
595
572
584
517
420
379
352
Shares outstanding
35
34.2
34.4
34.8
35.8
45.7
43.8
38.9
36.9
36.2
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-29.6
84.9
-3.9
-21.8
345
56.7
-8.04
-36.6
-54.3
-29.7
Depreciation and amortization
25.4
28.1
32
32.7
16.5
14.2
15
16.7
16.2
13
Stock-based compensation
3.84
2.34
4.41
6.95
6.7
7.7
6.04
7.22
6.21
2.18
Deferred income tax
0.03
0.06
-43.9
1.01
0.25
-13.9
-8.38
-15.2
Change in receivables
0.29
-22.2
8.29
-19.8
-19.3
7.51
10.3
1.91
2.72
-2.99
Change in inventory
-0.56
-8.08
-35
-14.7
-0.82
-5.94
-12.6
2.37
-1.58
-5.8
Change in payables
-4.16
10.3
-8.39
Cash from operations
9.37
-20.3
39.2
50.5
7.47
87.7
5.17
-3.01
-6.13
-24.2
Capital expenditures
-18.7
-32.7
-28.9
-23
-36.1
-32.2
-23.4
-6.96
-11.6
-30
Cash from investing
1.04
-35.4
-33.3
-28.9
318
-31.4
-24.9
-7.66
-11.7
-24.4
Debt issued
86.3
Debt repaid
-2.23
-1.18
-224
Stock issued
1.73
3.74
1.13
2.86
3.92
4.28
1.79
0.03
0
Share buybacks
-11.4
-1.61
-2.7
-1.13
-1.65
-14
-51.8
-12.9
-4.38
Cash from financing
1.73
72.7
1.29
-1.8
-222
-35.5
-12.7
-52.3
16.6
12
Exchange rate effect
-1.42
9.9
-3.36
-0.58
24.6
-21.2
-21.6
-4.38
-18.2
1.76
Net change in cash
10.7
27
3.86
19.2
128
-0.39
-54.1
-67.4
-19.5
-34.9
Free cash flow
-9.36
-52.9
10.3
27.5
-28.6
55.5
-18.2
-9.97
-17.7
-54.2
Interest paid
14.9
17.6
19.3
19.1
22.2
2.09
0
0.97
1.25
Income taxes paid
0.69
1.03
0.92
2.08
23.1
12.7
19
1.44
1.34
1.93
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $3.30 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
15.9%
Gross profit / revenue.
Operating margin
-23.2%
Operating income / revenue.
EBITDA margin
-15.9%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-27.6%
Pre-tax income / revenue.
Net margin
-17.3%
Net income / revenue.
FCF margin
-30.5%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-13.6%
Cash from operations / revenue.
Return on equity (ROE)
-13.5%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-9.4%
Net income / average total assets.
Return on invested capital (ROIC)
-18.0%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
16.9%
Research and development expense / revenue.
SG&A / revenue
18.8%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
1.2%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
16.9%
Capital expenditures / revenue.
D&A / revenue
7.3%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-8.9%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-19.1%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
-18.8%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
-18.9%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
-32.3%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
-24.5%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y
-10.3%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-16.6%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y
-6.4%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
-7.3%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-12.0%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-9.3%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
-4.1%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
-6.9%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
-4.9%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
2.43x
Current assets / current liabilities.
Quick ratio
1.65x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
1.30x
(Cash + short-term investments) / current liabilities.
Debt / equity
0.18x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
12.8%
Total debt / total assets.
Liabilities / assets
30.3%
Total liabilities / total assets.
Net debt
-$46.4M
Total debt - cash - short-term investments. Negative means more cash than debt.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$0.84
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$4.87
Revenue / diluted weighted shares.
FCF per share
-$1.49
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.66
Cash from operations / diluted weighted shares.
Book value per share
$6.20
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
0.68x
Market cap / revenue.
P/B
0.53x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
0.53x
Market cap / tangible book value, when positive.
EV/Sales
0.42x
Enterprise value / revenue.
FCF yield
-45.0%
Free cash flow / market cap.
Earnings yield
-25.4%
Net income / market cap (the inverse of P/E).
Shareholder yield
3.6%
(Dividends paid + share buybacks) / market cap.
What was MAGNACHIP SEMICONDUCTOR Corp's revenue in fiscal 2025?
MAGNACHIP SEMICONDUCTOR Corp reported revenue of $178.9M for fiscal 2025, 8.9% lower than the year before.
Was MAGNACHIP SEMICONDUCTOR Corp profitable in fiscal 2025?
No. It reported a net loss of $29.7M.
How much free cash flow did MAGNACHIP SEMICONDUCTOR Corp generate in fiscal 2025?
Cash from operations of $24.2M minus capital expenditures of $30.0M left free cash flow of -$54.2M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.